The physiological significance of galectin‐3/FGFR1 interplay is currently unknown,however, the high‐affinity tetravalent antibody described in this study can be used to partially uncouple galectin‐3/FGFR1 interaction, which may be of potential relevance for therapeutic purposes in cancer treatment. This evidence concerns the gene FGFR1 and cancer.